# Invesco Galaxy Ethereum ETF: financial statements, quarterly

QETH · CBOE · CIK 1995569 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qeth.md) · [Financials](/companies/qeth/financials.md) · [Filings](/companies/qeth/filings.md) · [Insiders](/companies/qeth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qeth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(0.0)](/filings/0001193125-25-270284.md) | [(0.0)](/filings/0001193125-26-209708.md) | [(0.0)](/filings/0001193125-26-338689.md) | [(0.0)](/filings/0001193125-25-270284.md) | [(0.0) d](/filings/0001193125-26-083578.md) | [(0.0)](/filings/0001193125-26-209708.md) | [(0.0)](/filings/0001193125-26-338689.md) |
| Net income | $m | [(3.5)](/filings/0001193125-25-270284.md) | [(11.4)](/filings/0001193125-26-209708.md) | [5.5](/filings/0001193125-26-338689.md) | [14.1](/filings/0001193125-25-270284.md) | [(10.1) d](/filings/0001193125-26-083578.md) | [(7.5)](/filings/0001193125-26-209708.md) | [(5.0)](/filings/0001193125-26-338689.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2024-06-16) | Q2 FY2025 (2024-06-30) | Q3 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.1](/filings/0000950170-24-101684.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [0.1](/filings/0000950170-24-101684.md) | [20.4](/filings/0000950170-24-122612.md) | [23.6](/filings/0001193125-26-083578.md) | [13.7](/filings/0000950170-25-067226.md) | [22.7](/filings/0000950170-25-105149.md) | [39.0](/filings/0001193125-25-270284.md) | [25.9](/filings/0001193125-26-338689.md) | [18.9](/filings/0001193125-26-209708.md) | [15.6](/filings/0001193125-26-338689.md) |
| Total liabilities | $m | not reported | [0.0](/filings/0000950170-24-101684.md) | [0.0](/filings/0000950170-24-122612.md) | [0.0](/filings/0001193125-26-083578.md) | [0.0](/filings/0000950170-25-067226.md) | [0.0](/filings/0000950170-25-105149.md) | [0.0](/filings/0001193125-25-270284.md) | [0.0](/filings/0001193125-26-338689.md) | [0.0](/filings/0001193125-26-209708.md) | [0.0](/filings/0001193125-26-338689.md) |
| Shareholders' equity | $m | [0.0](/filings/0001193125-26-083578.md) | [0.1](/filings/0001193125-25-270284.md) | [20.4](/filings/0001193125-25-270284.md) | [23.6](/filings/0001193125-26-338689.md) | [13.7](/filings/0001193125-26-338689.md) | [22.6](/filings/0001193125-26-338689.md) | [39.0](/filings/0001193125-25-270284.md) | [25.8](/filings/0001193125-26-338689.md) | [18.9](/filings/0001193125-26-338689.md) | [15.6](/filings/0001193125-26-338689.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(23.9)](/filings/0001193125-25-270284.md) | [4.4 d](/filings/0001193125-26-083578.md) | [(1.6)](/filings/0001193125-26-209708.md) | [(3.4) d](/filings/0001193125-26-338689.md) | [(2.2) d](/filings/0001193125-25-270284.md) | [3.1 d](/filings/0001193125-26-083578.md) | [(0.5)](/filings/0001193125-26-209708.md) | [(1.7) d](/filings/0001193125-26-338689.md) |
| Share repurchases | $m | [0.1](/filings/0001193125-25-270284.md) | [10.7 d](/filings/0001193125-26-083578.md) | [1.5](/filings/0001193125-26-209708.md) | [0.0 d](/filings/0001193125-26-338689.md) | [24.8 d](/filings/0001193125-25-270284.md) | [8.6 d](/filings/0001193125-26-083578.md) | [9.3](/filings/0001193125-26-209708.md) | [0.0 d](/filings/0001193125-26-338689.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 983,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338689.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.